SCHEMBL13653569

SCHEMBL13653569

O=C(NCCCNc1nc(Nc2cccc(CBr)c2)ncc1C1CC1)C1CCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 18/20 0.79
PDPK1 O15530 2/20 0.79
MARK3 P27448 4/20 0.75
ULK1 O75385 3/20 0.75
ULK2 Q8IYT8 3/20 0.75
IKBKE Q14164 3/20 0.75
MARK4 Q96L34 2/20 0.75
STK17A Q9UEE5 2/20 0.75
NUAK1 O60285 1/20 0.75
PRKAA2 P54646 1/20 0.75
SIK1 P57059 1/20 0.75
PRKAA1 Q13131 1/20 0.75
MELK Q14680 1/20 0.75
PDK1 Q15118 1/20 0.75
MARK2 Q7KZI7 1/20 0.75
NUAK2 Q9H093 1/20 0.75
SIK2 Q9H0K1 1/20 0.75
MARK1 Q9P0L2 1/20 0.75
SIK3 Q9Y2K2 1/20 0.75
CDK2 P24941 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13431829 0.92 TBK1 (0.80) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13432039 0.92 TBK1 (0.80) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL3384222 0.91 TBK1 (0.77) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13431894 0.90 TBK1 (0.81) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13431887 0.89 TBK1 (0.75) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13431882 0.89 TBK1 (0.72) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL3384531 0.89 TBK1 (0.82) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13431885 0.89 TBK1 (0.88) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13460110 0.88 TBK1 (0.81) TBK1PDPK1MARK3ULK1ULK2
SCHEMBL13431782 0.88 TBK1 (1.00) TBK1PDPK1MARK3ULK1ULK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009122180-A1 PYRIMIDINE DERIVATIVES CAPABLE OF INHIBITING ONE OR MORE KINASES MEDICAL RESEARCH COUNCIL (GB) 2009-10-08 WO disclosed